dudedude
liked
• US markets: Nasdaq-100 extends its rebound to 5.4% from its low. Strategy is up 29% in 8 days, AppLovin up 27%, Palantir up 21%, Tesla up 20%, CrowdStrike up 16%.
• Aussie markets: Uranium miners lead rebound. Boss Energy up 26% in 13 days, Deep Yellow up 13%. US fintech Block up 14%.
• Stocks to watch: Origin Energy, Origin, CSL, Cochlear, Sigma, Bega Cheese
The Aussie share market expected to rally foll...
• Aussie markets: Uranium miners lead rebound. Boss Energy up 26% in 13 days, Deep Yellow up 13%. US fintech Block up 14%.
• Stocks to watch: Origin Energy, Origin, CSL, Cochlear, Sigma, Bega Cheese
The Aussie share market expected to rally foll...
From YouTube
17
1
dudedude
liked
dudedude
liked
In this very news driven market, no tariff news means good news for the market.
The market is still taking comfort from signs that President Trump could offer flexibility ahead of the next major tariff deadline - 2 Apr.
Stocks have risen since last Friday.
PS: things work both ways. If Trump gives us some negative tariff news, the market can pull back faster than you could imagine.
$SPDR S&P 500 ETF (SPY.US)$ $S&P 500 Index (.SPX.US)$ $Invesco QQQ Trust (QQQ.US)$ $Alibaba (BABA.US)$ $BYD COMPANY (01211.HK)$ $Tesla (TSLA.US)$ $Super Micro Computer (SMCI.US)$ $iShares Bitcoin Trust (IBIT.US)$ $NVIDIA (NVDA.US)$ $Alphabet-A (GOOGL.US)$ $Meta Platforms (META.US)$ $Microsoft (MSFT.US)$ $MARA Holdings (MARA.US)$ $Advanced Micro Devices (AMD.US)$ $Taiwan Semiconductor (TSM.US)$ $Amazon (AMZN.US)$ $Netflix (NFLX.US)$ $Apple (AAPL.US)$
...
The market is still taking comfort from signs that President Trump could offer flexibility ahead of the next major tariff deadline - 2 Apr.
Stocks have risen since last Friday.
PS: things work both ways. If Trump gives us some negative tariff news, the market can pull back faster than you could imagine.
$SPDR S&P 500 ETF (SPY.US)$ $S&P 500 Index (.SPX.US)$ $Invesco QQQ Trust (QQQ.US)$ $Alibaba (BABA.US)$ $BYD COMPANY (01211.HK)$ $Tesla (TSLA.US)$ $Super Micro Computer (SMCI.US)$ $iShares Bitcoin Trust (IBIT.US)$ $NVIDIA (NVDA.US)$ $Alphabet-A (GOOGL.US)$ $Meta Platforms (META.US)$ $Microsoft (MSFT.US)$ $MARA Holdings (MARA.US)$ $Advanced Micro Devices (AMD.US)$ $Taiwan Semiconductor (TSM.US)$ $Amazon (AMZN.US)$ $Netflix (NFLX.US)$ $Apple (AAPL.US)$
...
From YouTube
7
dudedude
liked
Hey Mooers! ![]()
March Match enters into its last week! Learn from last week’s top traders’ strategies and seize your last chance to claim the $NVIDIA (NVDA.US)$ stock reward!
How did contestants perform last week?
Congratulations to these mooers who ranked Top10 in the March Match last week:
@LockStockN’Barrel @Persona888 @NotFar @Ryotaszk @151150781 @quick-witted Eagle_6 @攒钱买跑车 @152537396 @151779092 @152287690
And these mooers who ranked Top10 ...
March Match enters into its last week! Learn from last week’s top traders’ strategies and seize your last chance to claim the $NVIDIA (NVDA.US)$ stock reward!
Congratulations to these mooers who ranked Top10 in the March Match last week:
@LockStockN’Barrel @Persona888 @NotFar @Ryotaszk @151150781 @quick-witted Eagle_6 @攒钱买跑车 @152537396 @151779092 @152287690
And these mooers who ranked Top10 ...



+5
25
3
1
dudedude
liked
$NVIDIA (NVDA.US)$ Recently, NVIDIA (NASDAQ: NVDA) held the GTC 2025 (GPU Technology Conference), attracting significant attention from global investors and Wall Street Institutions. CEO Jensen Huang presented a series of future plans for AI-related technologies and products, further strengthening Nvidia's market leadership in high-performance computing (HPC) and AI chip sectors. However, despite Nvidia announcing a brand new Blackwell Ultra AI server and the AI product roadmap for the coming years, the stock price saw a 3.4% decline after the GTC conference, closing at $115.43Does this mean that the market has concerns about Nvidia's long-term growth? Or is the AI boom still worth following for investors? This article will analyze the investment opportunities and potential risks of Nvidia's GTC 2025 from multiple perspectives.Market trends, Earnings Reports data, and competitive landscape.and other various angles, providing a comprehensive analysis of Nvidia's investment opportunities and potential risks in GTC 2025.
AI business model evolution: Nvidia's core competitiveness remains solid.
The most important announcement at GTC 2025 is undoubtedly Nvidia's AI hardware development roadmap.The company announced that it will launch in 2025. Blackwell Ultra AI Server...
AI business model evolution: Nvidia's core competitiveness remains solid.
The most important announcement at GTC 2025 is undoubtedly Nvidia's AI hardware development roadmap.The company announced that it will launch in 2025. Blackwell Ultra AI Server...
Translated

10
dudedude
liked
Hi, mooers!
Guess who’s back? Time for your favorite part—Maple Market Challenge. This year, we are doubling down on rewards and dialing up the fun with topics that'll keep you glued! Let's go!
Now, get ready for today's vote! Participants with the right answer will receive 50 points for voting!
Canada's annual inflation rate surged to 2.6% in February, marking the fastest increase in eight months and exceeding analys...
Now, get ready for today's vote! Participants with the right answer will receive 50 points for voting!
Canada's annual inflation rate surged to 2.6% in February, marking the fastest increase in eight months and exceeding analys...

20
22
dudedude
liked
Options Trading Newsletter Issue #203 from Substack.
SYNTHETIC Stock ON XBI
The SPDR S&P Biotech ETF (XBI) is an equal-weighted ETF that tracks the S&P Biotechnology Select Industry Index. Unlike market-cap-weighted ETFs, XBI gives equal exposure to small, mid, and large biotech stocks. This makes it more volatile compared to other biotech ETFs like IBB, which is more weighted toward large-cap biotech firms.
XBI Price Action Analysis
– XBI has been on...
SYNTHETIC Stock ON XBI
The SPDR S&P Biotech ETF (XBI) is an equal-weighted ETF that tracks the S&P Biotechnology Select Industry Index. Unlike market-cap-weighted ETFs, XBI gives equal exposure to small, mid, and large biotech stocks. This makes it more volatile compared to other biotech ETFs like IBB, which is more weighted toward large-cap biotech firms.
XBI Price Action Analysis
– XBI has been on...

12
1
2